Ovarian cancer (OC) is often diagnosed at advanced stages, and resistance to platinum-based chemotherapy remains one of the leading causes of treatment failure. This resistance is sustained in part by metabolic plasticity, particularly through the de novo serine synthesis pathway (SSP), orchestrated by D-3-phosphoglyce...
Jesús Omar Velázquez-Moreno, María de la Luz Mejía-Aguayo, Felix De Dios Padre Casarrubias-Jaimes et al.· International Journal of Mol...· 0 citations
Survival outcomes in this cohort are markedly lower than in high-income countries, and improving survival requires complementing biological risk stratification with targeted strategies to overcome socioeconomic barriers and prevent treatment non-adherence.
Francisca Morales-Vital, Diego Moreno-Loaeza, V. M. Alvarado-Castro et al.· Journal of Clinical Medicine· 0 citations
This study identified differentially expressed proteins (DEPs) associated with the progression of premalignant lesions to SCC that may represent candidate biomarkers and therapeutic targets warranting further investigation.
Diana Laura Gonzalez-Tolentino, O. L. Garibay-Cerdenares, S. Encarnación-Guevara et al.· Pathogens· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.